Cargando…
Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2
Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a 5′-tyrosyl DNA phosphodiesterase important for the repair of DNA adducts generated by non-productive (abortive) activity of topoisomerase II (TOP2). TDP2 facilitates therapeutic resistance to topoisomerase poisons, which are widely used in the treatment of...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925160/ https://www.ncbi.nlm.nih.gov/pubmed/27099339 http://dx.doi.org/10.1042/BCJ20160180 |
_version_ | 1782439954917359616 |
---|---|
author | Hornyak, Peter Askwith, Trevor Walker, Sarah Komulainen, Emilia Paradowski, Michael Pennicott, Lewis E. Bartlett, Edward J. Brissett, Nigel C. Raoof, Ali Watson, Mandy Jordan, Allan M. Ogilvie, Donald J. Ward, Simon E. Atack, John R. Pearl, Laurence H. Caldecott, Keith W. Oliver, Antony W. |
author_facet | Hornyak, Peter Askwith, Trevor Walker, Sarah Komulainen, Emilia Paradowski, Michael Pennicott, Lewis E. Bartlett, Edward J. Brissett, Nigel C. Raoof, Ali Watson, Mandy Jordan, Allan M. Ogilvie, Donald J. Ward, Simon E. Atack, John R. Pearl, Laurence H. Caldecott, Keith W. Oliver, Antony W. |
author_sort | Hornyak, Peter |
collection | PubMed |
description | Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a 5′-tyrosyl DNA phosphodiesterase important for the repair of DNA adducts generated by non-productive (abortive) activity of topoisomerase II (TOP2). TDP2 facilitates therapeutic resistance to topoisomerase poisons, which are widely used in the treatment of a range of cancer types. Consequently, TDP2 is an interesting target for the development of small molecule inhibitors that could restore sensitivity to topoisomerase-directed therapies. Previous studies identified a class of deazaflavin-based molecules that showed inhibitory activity against TDP2 at therapeutically useful concentrations, but their mode of action was uncertain. We have confirmed that the deazaflavin series inhibits TDP2 enzyme activity in a fluorescence-based assay, suitable for high-throughput screen (HTS)-screening. We have gone on to determine crystal structures of these compounds bound to a ‘humanized’ form of murine TDP2. The structures reveal their novel mode of action as competitive ligands for the binding site of an incoming DNA substrate, and point the way to generating novel and potent inhibitors of TDP2. |
format | Online Article Text |
id | pubmed-4925160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49251602016-07-12 Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 Hornyak, Peter Askwith, Trevor Walker, Sarah Komulainen, Emilia Paradowski, Michael Pennicott, Lewis E. Bartlett, Edward J. Brissett, Nigel C. Raoof, Ali Watson, Mandy Jordan, Allan M. Ogilvie, Donald J. Ward, Simon E. Atack, John R. Pearl, Laurence H. Caldecott, Keith W. Oliver, Antony W. Biochem J Research Articles Tyrosyl-DNA phosphodiesterase 2 (TDP2) is a 5′-tyrosyl DNA phosphodiesterase important for the repair of DNA adducts generated by non-productive (abortive) activity of topoisomerase II (TOP2). TDP2 facilitates therapeutic resistance to topoisomerase poisons, which are widely used in the treatment of a range of cancer types. Consequently, TDP2 is an interesting target for the development of small molecule inhibitors that could restore sensitivity to topoisomerase-directed therapies. Previous studies identified a class of deazaflavin-based molecules that showed inhibitory activity against TDP2 at therapeutically useful concentrations, but their mode of action was uncertain. We have confirmed that the deazaflavin series inhibits TDP2 enzyme activity in a fluorescence-based assay, suitable for high-throughput screen (HTS)-screening. We have gone on to determine crystal structures of these compounds bound to a ‘humanized’ form of murine TDP2. The structures reveal their novel mode of action as competitive ligands for the binding site of an incoming DNA substrate, and point the way to generating novel and potent inhibitors of TDP2. Portland Press Ltd. 2016-06-28 2016-07-01 /pmc/articles/PMC4925160/ /pubmed/27099339 http://dx.doi.org/10.1042/BCJ20160180 Text en © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Articles Hornyak, Peter Askwith, Trevor Walker, Sarah Komulainen, Emilia Paradowski, Michael Pennicott, Lewis E. Bartlett, Edward J. Brissett, Nigel C. Raoof, Ali Watson, Mandy Jordan, Allan M. Ogilvie, Donald J. Ward, Simon E. Atack, John R. Pearl, Laurence H. Caldecott, Keith W. Oliver, Antony W. Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title | Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title_full | Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title_fullStr | Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title_full_unstemmed | Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title_short | Mode of action of DNA-competitive small molecule inhibitors of tyrosyl DNA phosphodiesterase 2 |
title_sort | mode of action of dna-competitive small molecule inhibitors of tyrosyl dna phosphodiesterase 2 |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925160/ https://www.ncbi.nlm.nih.gov/pubmed/27099339 http://dx.doi.org/10.1042/BCJ20160180 |
work_keys_str_mv | AT hornyakpeter modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT askwithtrevor modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT walkersarah modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT komulainenemilia modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT paradowskimichael modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT pennicottlewise modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT bartlettedwardj modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT brissettnigelc modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT raoofali modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT watsonmandy modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT jordanallanm modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT ogilviedonaldj modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT wardsimone modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT atackjohnr modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT pearllaurenceh modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT caldecottkeithw modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 AT oliverantonyw modeofactionofdnacompetitivesmallmoleculeinhibitorsoftyrosyldnaphosphodiesterase2 |